Patents

US 8309104 B2: Oral controlled release formulation for sedative and hypnotic agents

Granted
2012-11-13
Filed
2007-02-28 application 11712133
Type
Utility · 10 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic levels for about eight hours after administration.

Source: PVGPATDIS, file of 2026-04-10 (ipg121113.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Watson Pharmaceuticals, Inc. 6 patentsUS company or organizationCorona, CAPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Xiu Xiu ChengWeston, FL8PVGPATDIS, file of 2026-04-10
Dacheng TianMiramar, FL1PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K9/2846PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/20PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2017-01-20Name change
Change of name
ACTAVIS, INC. signed 2016-06-09ALLERGAN FINANCE, LLC PARSIPPANY, NJ41459/788ECORSEXC, file of 2026-09-25
2017-01-20Assignment
Assignment of assignor's interest
ALLERGAN FINANCE, LLC signed 2016-07-19ACTAVIS HOLDCO US, INC. PARSIPPANY, NJ41449/799ECORSEXC, file of 2026-09-25
2017-01-20Name change
Change of name
WATSON PHARMACEUTICALS, INC. signed 2013-01-17ACTAVIS, INC. PARSIPPANY, NJ41023/542ECORSEXC, file of 2026-09-25
2007-02-28Assignment
Assignment of assignor's interest
CHENG, XIU XIU signed 2007-02-28
TIAN, DACHENG signed 2007-02-28
WATSON PHARMACEUTICALS, INC. CORONA, CA19049/227ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.